Indaptus Therapeutics (NASDAQ:INDP) Releases Earnings Results, Beats Estimates By $0.07 EPS
Indaptus Therapeutics (NASDAQ:INDP – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.47) EPS for the quarter, topping analysts’ consensus estimates of ($0.54) by $0.07, Zacks reports. Indaptus Therapeutics Stock Performance Shares of NASDAQ:INDP traded up $0.01 during mid-day trading on Wednesday, reaching $1.68. 3,399 shares of the company’s stock […]
More Stories
TD Securities Cuts Talon Metals (TSE:TLO) Price Target to C$0.30
Talon Metals (TSE:TLO – Free Report) had its price target decreased by TD Securities from C$0.55 to C$0.30 in a...
Streamline Health Solutions (NASDAQ:STRM) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Free Report) in a report published on Monday morning....
Reading International (NASDAQ:RDI) Now Covered by StockNews.com
StockNews.com began coverage on shares of Reading International (NASDAQ:RDI – Free Report) in a report issued on Monday. The firm...
Symbolic Logic (NASDAQ:EVOL) Now Covered by StockNews.com
StockNews.com started coverage on shares of Symbolic Logic (NASDAQ:EVOL – Free Report) in a research report sent to investors on...
Remark (NASDAQ:MARK) Coverage Initiated by Analysts at StockNews.com
StockNews.com started coverage on shares of Remark (NASDAQ:MARK – Free Report) in a research report released on Monday. The firm...
StockNews.com Downgrades Lithia Motors (NYSE:LAD) to Sell
Lithia Motors (NYSE:LAD – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in...